Goldman Sachs, Morgan Stanley, Cowen and Allen & Co. are acting as joint book running managers for the offering.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PACB:
- Pacific Biosciences announces $150M common stock offering
- Pacific Biosciences downgraded to Neutral at Cantor Fitzgerald on valuation
- Pacific Biosciences downgraded to Neutral from Overweight at Cantor Fitzgerald
- Pacific Biosciences partners with University of Tokyo
- PacBio Announces Record Orders, Including Orders for 76 Revio Systems Received in the Fourth Quarter of 2022